Patents by Inventor Arundhathi Jeyabalan

Arundhathi Jeyabalan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREDICTION AND PREVENTION OF PREECLAMPSIA
    Publication number: 20130303455
    Abstract: The present disclosure relates to methods for assessing increased risk of preeclampsia in a pregnant woman. The methods described herein employ measuring relaxin levels, and optionally measuring C-reactive protein levels in a biological sample of a pregnant woman. The disclosure further encompasses methods of reducing risk of preeclampsia through administration of a pharmaceutical formulation of relaxin to a pregnant woman.
    Type: Application
    Filed: July 12, 2013
    Publication date: November 14, 2013
    Inventors: Dennis Stewart, Kirk P. Conrad, Arundhathi Jeyabalan, Marion Dahike
  • Prediction and prevention of preeclampsia
    Patent number: 8574851
    Abstract: The present disclosure relates to methods for detecting an increased risk of preeclampsia, determining the presence of preeclampsia, reducing the likelihood that preeclampsia will develop and treating preeclampsia. It also provides methods of measuring relaxin levels in a biological sample of a pregnant woman.
    Type: Grant
    Filed: November 24, 2009
    Date of Patent: November 5, 2013
    Assignees: Corthera, Inc., University of Pittsburgh-Of the Commonwealth System of Higher Education, University of Florida Research Foundation, Inc.
    Inventors: Dennis Stewart, Kirk P. Conrad, Arundhathi Jeyabalan
  • PREDICTION AND PREVENTION OF PREECLAMPSIA
    Publication number: 20130012441
    Abstract: The present disclosure relates to methods for assessing increased risk of preeclampsia in a pregnant woman. The methods described herein employ measuring relaxin levels, and optionally measuring C-reactive protein levels in a biological sample of a pregnant woman. The disclosure further encompasses methods of reducing the risk of preeclampsia and treating it, once it has occurred by administering a pharmaceutical formulation of relaxin to a pregnant woman.
    Type: Application
    Filed: February 16, 2012
    Publication date: January 10, 2013
    Inventors: Dennis Stewart, Kirk P. Conrad, Arundhathi Jeyabalan, Marion Dahike
  • PREDICTION AND PREVENTION OF PREECLAMPSIA
    Publication number: 20110281801
    Abstract: The present disclosure relates to methods for detecting an increased risk of preeclampsia, determining the presence of preeclampsia, reducing the likelihood that preeclampsia will develop and treating preeclampsia. It also provides methods of measuring relaxin levels in a biological sample of a pregnant woman.
    Type: Application
    Filed: November 24, 2009
    Publication date: November 17, 2011
    Applicant: University of Pittsburgh-Of the Comonwealth System
    Inventors: Dennis Stewart, Kirk P. Conrad, Arundhathi Jeyabalan
  • GENE EXPRESSION RELATED TO PREECLAMPSIA
    Publication number: 20110171650
    Abstract: Gene expression patterns contemporaneous with early placental development in the first trimester of preeclamptic versus unaffected pregnancies have been obtained. Observation of differences in these gene expression patterns has allowed the identification of biomarkers that are useful in predicting and monitoring preeclampsia. These biomarkers are also useful in screening potential therapeutics for efficacy in the prevention or treatment of preeclampsia.
    Type: Application
    Filed: September 16, 2009
    Publication date: July 14, 2011
    Applicants: University of Pittsburgh-Of the Commonwealth System of Higher Education, University of Florida Research Foundation, Inc.
    Inventors: Kirk P. Conrad, Arundhathi Jeyabalan, Sandra Anne Founds, William Allen Hogge